Life Insurance Corporation of India (LIC) has announced a reduction in its shareholding in Aurobindo Pharma Ltd. LIC’s stake in the company has decreased from 5.01% to 2.265% of the paid-up capital, with the number of shares dropping from 2,93,55,635 to 1,31,57,165. This disclosure was made in compliance with Regulation 30 of SEBI’s Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015.
The corporation has provided the required details in “Annexure – A,” and the notice is also available on LIC’s official website. This update is being shared with the stock exchanges for public dissemination.
